Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 41 studies | 49% ± 20% | |
pericyte | 39 studies | 75% ± 26% | |
smooth muscle cell | 33 studies | 81% ± 22% | |
endothelial cell | 27 studies | 32% ± 13% | |
connective tissue cell | 16 studies | 55% ± 22% | |
myofibroblast cell | 16 studies | 78% ± 20% | |
endothelial cell of artery | 12 studies | 29% ± 15% | |
type I pneumocyte | 11 studies | 62% ± 27% | |
platelet | 10 studies | 63% ± 17% | |
endothelial cell of vascular tree | 10 studies | 34% ± 23% | |
capillary endothelial cell | 9 studies | 19% ± 3% | |
basal cell | 9 studies | 37% ± 15% | |
mesothelial cell | 8 studies | 68% ± 29% | |
vein endothelial cell | 6 studies | 21% ± 5% | |
epithelial cell | 6 studies | 40% ± 16% | |
cardiac muscle cell | 6 studies | 49% ± 13% | |
megakaryocyte | 5 studies | 65% ± 20% | |
adipocyte | 5 studies | 22% ± 9% | |
myoepithelial cell | 5 studies | 68% ± 20% | |
ciliated cell | 5 studies | 17% ± 2% | |
podocyte | 4 studies | 86% ± 12% | |
adventitial cell | 4 studies | 41% ± 14% | |
macrophage | 3 studies | 24% ± 7% | |
type II pneumocyte | 3 studies | 43% ± 27% | |
Mueller cell | 3 studies | 48% ± 6% | |
muscle cell | 3 studies | 87% ± 10% | |
secretory cell | 3 studies | 39% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 89% | 134766.94 | 219 / 245 | 99% | 1125.70 | 497 / 502 |
adrenal gland | 85% | 46900.23 | 220 / 258 | 80% | 464.91 | 183 / 230 |
uterus | 94% | 132416.00 | 159 / 170 | 71% | 452.13 | 325 / 459 |
bladder | 86% | 241057.57 | 18 / 21 | 78% | 292.57 | 391 / 504 |
breast | 62% | 31023.15 | 283 / 459 | 94% | 298.14 | 1047 / 1118 |
intestine | 74% | 259997.67 | 718 / 966 | 80% | 234.01 | 424 / 527 |
esophagus | 75% | 272697.20 | 1087 / 1445 | 70% | 225.47 | 128 / 183 |
ovary | 43% | 26921.96 | 78 / 180 | 100% | 456.14 | 428 / 430 |
lung | 53% | 25536.50 | 307 / 578 | 86% | 263.53 | 994 / 1155 |
stomach | 43% | 101842.52 | 155 / 359 | 85% | 407.15 | 242 / 286 |
thymus | 21% | 10156.53 | 135 / 653 | 94% | 370.17 | 568 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 564.28 | 1 / 1 |
blood vessel | 100% | 351693.81 | 1332 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 189.79 | 79 / 80 |
pancreas | 0% | 0 | 0 / 328 | 96% | 506.87 | 171 / 178 |
kidney | 8% | 4093.97 | 7 / 89 | 84% | 238.62 | 754 / 901 |
heart | 90% | 79128.90 | 775 / 861 | 0% | 0 | 0 / 0 |
skin | 8% | 3738.72 | 148 / 1809 | 63% | 116.58 | 295 / 472 |
adipose | 70% | 43074.34 | 843 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 81.46 | 17 / 29 |
tonsil | 0% | 0 | 0 / 0 | 40% | 66.70 | 18 / 45 |
liver | 0% | 0 | 0 / 226 | 38% | 91.12 | 153 / 406 |
brain | 0% | 108.96 | 5 / 2642 | 20% | 29.90 | 142 / 705 |
spleen | 5% | 2132.63 | 11 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 630.88 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030239 | Biological process | myofibril assembly |
GO_0070527 | Biological process | platelet aggregation |
GO_0006937 | Biological process | regulation of muscle contraction |
GO_0001725 | Cellular component | stress fiber |
GO_0030016 | Cellular component | myofibril |
GO_0005829 | Cellular component | cytosol |
GO_0005859 | Cellular component | muscle myosin complex |
GO_0005938 | Cellular component | cell cortex |
GO_0030018 | Cellular component | Z disc |
GO_0005737 | Cellular component | cytoplasm |
GO_0032036 | Molecular function | myosin heavy chain binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008307 | Molecular function | structural constituent of muscle |
Gene name | MYL9 |
Protein name | Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1) |
Synonyms | MYRL2 MRLC1 MLC2 |
Description | FUNCTION: Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Implicated in cytokinesis, receptor capping, and cell locomotion . In myoblasts, may regulate PIEZO1-dependent cortical actomyosin assembly involved in myotube formation (By similarity). . |
Accessions | ENST00000279022.7 [P24844-1] Q6IBG1 ENST00000346786.2 [P24844-2] P24844 |